Can anyone advise me (or point me in the right direction) on powering
dose-response clinical trials, particularly those for which the primary
endpoint is binary?
Thanks
Pete
The information contained in this email is intended for the
personal and confidential use of the addressee only. It may
also be privileged information. If you are not the intended
recipient then you are hereby notified that you have received
this document in error and that any review, distribution or
copying of this document is strictly prohibited. If you have
received this communication in error, please notify Celltech
immediately on:
+44 (0)1753 534655, or email [log in to unmask]
Celltech Group plc
208 Bath Road, Slough, SL1 3WE, Berkshire, UK
Registered Office as above.
|